A clinical objective focused on increasing the duration an individual experiences full physiological function and freedom from age-related morbidity, rather than merely extending chronological lifespan. This requires intervening against the hallmarks of aging at the molecular and systemic levels concurrently. The primary aim is maximizing years lived in robust, high-functioning health.
Origin
This term arises from the field of geroscience, distinguishing between simple longevity and the more valuable metric of “healthspan.” It reflects a translational shift in focus toward maintaining physiological reserve capacity across systems. The concept integrates insights from cellular senescence, proteostasis, and epigenetic regulation as targets for intervention.
Mechanism
Protocols supporting this extension often target senescent cell clearance, modulate nutrient sensing pathways like IGF-1 signaling, and enhance DNA damage response mechanisms through supportive therapies. By reducing the cumulative burden of molecular damage, the overall rate of physiological decline is theoretically slowed across multiple axes. Successful implementation aims to compress the period of morbidity late in life, preserving functional autonomy.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.